No Detail Found!

Safety of Methotrexate and Leflunomide as a Combination Therapy in Patients of Rheumatoid Arthritis.

Author(s)
Saba Samreen Fauji Foundation Hospital Rawalpindi Pakistan
Babur Salim Fauji Foundation Hospital Rawalpindi Pakistan
Amjad Nasim Fauji Foundation Hospital Rawalpindi Pakistan
Abstract
Objective: To study the safety profile of MTX+LEF combination in patients with active RA at 03 and 06 months. Study Design: Quasi-experimental study. Place and Duration of Study: Rheumatology department, Fauji Foundation Hospital Rawalpindi, from Jun 2015 to Dec 2015. Material and Methods: This quasi-experimental study was conducted at Rheumatology department, Fauji Foundation Hospital, Rawalpindi. Seventy two patients who had an active RA despite optimal dose (2025mg/week) of MTX were enrolled and leflunomide 20mg/day was added. Patients underwent clinical and laboratory review at 0, 1, 3 and 6 months to note any adverse effects. Results: Seventy two patients were enrolled with a mean age (years) ± SD of 51.5 ± 9.1 and a mean duration of disease (years) of 8.25 ± 6.1. Patients had active disease at baseline with a mean disease activity score (DAS28) of 6.2 ± 0.7. At 6 months the most frequent side effects (mostly mild); were abdominal pain and nausea. Fifty Seven patients (79.1%) continued with the combination therapy. Only 3 patients stopped the treatment temporarily (due to raised ALT and vomiting). Twelve patients discontinued treatment due to diarrhea, severe oral ulcers, markedly raised ALT; (Each affecting 2 patients) and severe vomiting, abscess, MTX Induced pneumonitis, severe chest infection (each affecting 1 patient). Conclusion: MTX + LEF combination is safe to use in RA patients if vigilant clinical and laboratory monitoring is ensured.
Publication Details
Page(s) 988-995
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 67, Issue: 6, Year: 2017

Request the full text from PASTIC

References
TuressonC,O'fallonWM,CrowsonCS,GabrielSE,MattesonEL,,2003,Extra-articular disease manifestations in rheumatoid arthritis: Incidence trends and risk factors over 46 years,Ann Rheum Dis,62,722,7
PavelkaK,KavanaughA,RubbertA,FerraccioliG,,2012,Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs,J Rheumatolo,51 Suppl-5,12,21
CronsteinBN,,1951,Molecular therapeutics. Methotrexate and its mechanism of action,Arthritis Rheum,39,,
AletahaD,FunovitsJ,KeystoneEC,SmolenJS,,2007,Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients,Arthritis Rheum,56,3226,
O'Dell,JR , Leff,R , Paulsen,G , Haire,C , Mallek,J , Eckhoff,PJ,,2002,Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: Results of a two-year, randomized, double blind, placebo controlled trial,Arthritis & Rheumatism,46,1164,70
ScottDL,KingsleyGH,,2006,Tumor necrosis factor inhibitors for rheumatoid arthritis,N Engl J Med,355,704,
KremerJ,GenoveseM,CannonGW,CaldwellJ,CushJ,FurstDE,,2004,Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: Open-label extension of a randomized, double-blind, placebo controlled trial,J rheumatol,31,1521,31
CurtisJR,BeukelmanT,OnofreiA,CassellS,GreenbergJD,KavanaughA,,2010,Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide,Ann Rheum Dis,69,43,7
AlvesJA,FialhoSC,MoratoEF,CastroGR,ZimmermannAF,RibeiroGG,,2011,Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate,,51,141,4
AhmadNM,FarmanS,SaeedMA,HameedR,UmairM,GhafoorE.,,2011,Leflunomide in Pakistani patients with rheumatoid arthritis: Prospective study in daily rheumatology practice,International journal of rheumatic diseases,14,48,54
ArnettFC,,1987,The 1987 revised ARA criteria for rheumatoid arthritis,Arthritis Rheum,17,,
Van der HeijdeDM,Van't HofM,Van RielPL,Van de Putte LB,,1993,Development of a disease activity score based on judgment in clinical practice by rheumatologists,J Rheumatol,20,579,81
British,,2015,Medical Association and the Royal Pharmaceutical Society of Great Britain,British National Formulary. 70th ed. UK: BMJ Publishing Group,,,
Singh , JA,SaagKG,BridgesSL,AklEA,BannuruRR,SullivanMC,,2016,American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis,Arthritis Care Res,68,1,25
SmolenJS,BreedveldFC,BurmesterGR,BykerkV,DougadosM,EmeryP,,2016,Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force,Ann Rheum Dis,75,3,15
StofferMA,SchoelsMM,SmolenJS,AletahaD,BreedveldFC,BurmesterG,,2016,Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update,Ann Rheum Dis,75,16,22
GullickNJ,OakleySP,ZainA,GibsonT,JonesT,MistlinA,,2012,Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years,J Rheumatolo,51,759,61
O'Dell,JR , Haire,CE , Erikson,N , Drymalski,W , Palmer,W , Eckhoff,PJ,,1996,Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications,N Engl J Med,334,1287,91
PopeJE,HaraouiB,RampakakisE,PsaradellisE,ThorneC,SampalisJS,,2013,Treating to a target in established active rheumatoid arthritis patients receiving a tumor necrosis factor inhibitor: Results from a real-world cluster randomized adalimumab trial,Arthritis care & research,65,1401,9
,2013,The SMILE study - Safety of methotrexate in combination with leflunomide in rheumatoid arthritis,J Rheumatol,40,228,35
HensleyG.,,2010,Good long-term tolerance of methotrexate plus leflunomide in minority patients with rheumatoid arthritis,Ann Rheum Dis,69,216,
CubidesMF,Fernandez AvilaDG,,2010,Use of leflunomide plus methotrexate combination in a group of patients with active rheumatoid arthritis in Colombia. It's not so bad!,Ann Rheum Dis,69,684,
0

Citations

0

Downloads

74

Views